The Effect of Progesterone Dose on Gene Expression after Traumatic Brain Injury
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Microarray-based transcriptional profiling was used to determine the effect of progesterone in the cortical contusion (CCI) model. Gene ontology (GO) analysis then evaluated the effect of dose on relevant biological pathways. Treatment (vehicle, progesterone 10 mg/kg or 20 mg/kg given i.p.) was started 4 h post-injury and administered every 12 h post-injury for up to 72 h, with the last injection 12 hr prior to death for the 24 h and 72 h groups. In the CCI-injured vehicle group compared to non-injured animals, expression of 1,114, 4,229, and 291 distinct genes changed >1.5-fold (p<0.05) at 24 h, 72 h, and 7 days, respectively. At 24 h, the effect of low-dose progesterone on differentially expressed genes was <20% the effect of higher dose compared to vehicle. GO analysis identified a significant effect of low- and high-dose progesterone treatment compared to vehicle on DNA damage response. At 72 h, high-dose progesterone treatment compared to vehicle affected expression of almost twice as many genes as did low-dose progesterone. Both low- and high-dose progesterone resulted in expression of genes regulating inflammatory response and apoptosis. At 7 days, there was only a modest difference in high-dose progesterone compared to vehicle, with only 14 differentially expressed genes. In contrast, low-dose progesterone resulted in 551 differentially expressed genes compared to vehicle. GO analysis identified genes for the low-dose treatment involved in positive regulation of cell proliferation, innate immune response, positive regulation of anti-apoptosis, and blood vessel remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“Progesterone has been shown previously to modulate the activity of neurotransmitters, including positive modulation of c-aminobutyric acid type A (GABAA) receptors, primarily by allopregnanolone, the active metabolite of progesterone (Belelli et al., 2002; Majewska et al., 1986).”
BackgroundMicroarray data analysis: from disarray to consolidation and consensus
Allison, D. B., Cui, X., Page, G. P., & Sabripour, M. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1749 · Cited by 1,339 · cited 1×
“Such an adjustment has repeatedly been shown to avoid an excess of false positives when identifying differentially expressed genes (Allison et al., 2006).”
BackgroundClinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology
Malavasi, F., Deaglio, S., Funaro, A., Ferrero, E., Horenstein, A. L., Ortolan, E., Vaisitti, T., & Aydin, S. (2008) · Physiological Reviews · doi:10.1152/physrev.00035.2007 · Cited by 862 · cited 2×
“CD38 is expressed in the brain and can catalyze the formation of cyclic ADP-ribose from nicotinamide adenine dinucleotide (NAD + ), a reaction that is essential for the regulation of intracellular Ca(2) + (Malavasi et al., 2008).”
BackgroundIshrat, T., Sayeed, I., Atif, F., Hua, F., & Stein, D. G. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.023 · Cited by 159 · cited 7×
“In contrast to our results, in an ischemic rodent stroke model, progesterone administration (8 mg/kg subcutaneously) at 1, 6, 24, and 48 h decreased the expression of MMP-9 (Ishrat et al., 2010).”
BackgroundResultInfluentialNeuroprotection in traumatic brain injury: a complex struggle against the biology of nature
Schouten, J. W. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3280895d5c · Cited by 152
Rubovitch, V., Edut, S., Sarfstein, R., Werner, H., & Pick, C. G. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.021 · Cited by 61 · cited 1×
“Igf1, a neutrophic factor, has been shown to be neuroprotective in models of brain and spinal cord injury (Perez-Martin et al., 2010; Rubovitch et al., 2011).”
Background
Cited by
Diaz-Arrastia, R., Kochanek, P. M., Bergold, P., Kenney, K., Marx, C. E., Grimes, C. J. B., Loh, L. Y., Adam, L. G. E., Oskvig, D., Curley, K. C., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3019 · Cited by 262
Embracing failure: What the Phase III progesterone studies can teach about TBI clinical trials
Stein, D. G. (2015) · Brain Injury · doi:10.3109/02699052.2015.1065344 · Cited by 249
Gender impacts mortality after traumatic brain injury in teenagers
Ley, E. J., Short, S. S., Liou, D. Z., Singer, M. B., Mirocha, J., Melo, N., Bukur, M., & Salim, A. (2013) · Journal of Trauma and Acute Care Surgery · doi:10.1097/ta.0b013e31829d024f · Cited by 74
Ischemia/reperfusion induces interferon stimulated gene expression in microglia
McDonough, A., Lee, R. V., Noor, S., Lee, C., Le, T., Iorga, M., Phillips, J. L. H., Murphy, S., Möller, T., & Weinstein, J. R. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0725-17.2017 · Cited by 71
“0 ST Arrays (Affymetrix) as described previously (Anderson et al., 2011).”
MethodInfluential
Metadata
- Authors
- Anderson, G. D., Farin, F. M., Bammler, T. K., Beyer, R. P., Swan, A. A., Wilkerson, H.-W., Kantor, E. D., & Hoane, M. R.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2011-09
- Volume
- 28
- Issue
- 9
- Pages
- 1827-1843
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2035174661
- Cited by
- 50
- References
- 7
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.